Fri, 30 Mar 2012 | DIVISION SALE
Scottish bus firm FirstGroup has placed part of its operations on the market with the aim of generating £100 million in cash.
The move is part of a strategy to “significantly reposition" its business after announcing falling profits due to a decrease in passenger numbers in Scotland and the North of England. Its operations in these areas of the UK account for 60 per cent of its overall turnover and a third of its operating profits.
The parts of the group that are to be sold off were not revealed, but analysts estimate that they bring in between £130 million and £140 million for FirstGroup, representing 11.7 per cent of its total £1.2 billion of sales.
FirstGroup operates 8,000 buses across 40 locations in the UK. Its stronger areas in the South have reported a 3.3 per cent increase in passenger numbers, with a 0.4 per cent rise in Scotland and North England.
With cash-strapped customers still deciding to stay at home rather than visit the shops in the weaker performing regions, FirstGroup says neither cost cuts or fare hikes would counterbalance the effects of higher petrol bills and lower government subsidies, Scotsman.com reported.
FirstGroup began its disposals last year with the sale of its German unit to Marwyn European Transport for £4.8 million, while this year Stagecoach is due to shortly take over its North Devon bus arm for £2.8 million.
In separate news, FirstGroup is in the bidding process to operate the Thameslink, Great Western and Essex Thameside rail franchises.
This unique and renowned freehold bar and restaurant in the heart of York City Centre offers over 250 covers across its spacious interior, pavement seating, and a rare rooftop terrace.
FREEHOLD
A well established and strongly profitable engineering business, located in the Midlands. The company will be an attractive acquisition for both a larger trade buyer and also those looking for a stable engineering business.
This European pharmacy manufacturer specialises in providing custom clinical trial batches for leading pharmacy companies across the continent, playing a crucial role in their R&D efforts.
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.